Biology subjects

Ajayi, O. S.

Publications and source records attributed to Ajayi, O. S..

2 recordsLinked to original sources

bioRxiv2023

Understanding the Mechanisms of Salmonella Typhimurium resistance to Cannabidiol

The emergence of multidrug resistance poses a huge risk to public health globally. Yet these recalcitrant pathogens continue to rise in incidence rate with resistance rates significantly outpacing the speed of antibiotic development. This therefore presents an aura of related health issues such as untreatable nosocomial infections arising from organ transplants, surgeries, as well as community acquired infections that are related to people with compromised immunity e.g., diabetic and HIV patients etc. There is a global effort to fight multidrug resistant pathogens spearheaded by the World Health Organization, thus calling for research into novel antimicrobials agents to fight multiple drug resistance. Previously, our laboratory demonstrated that Cannabidiol (CBD) was an effective antimicrobial against Salmonella Typhimurium (S. Typhimurium). However, we observed resistance development over time. To understand the mechanisms S. Typhimurium uses to develop resistance to Cannabidiol (CBD), we studied the abundance of bacteria lipopolysaccharide (LPS) and membrane sterols of both susceptible and resistant S. Typhimurium. Using real-time quantitative polymerase chain reaction (rt qPCR), we also analyzed the expression of selected genes known for aiding resistance development in S. Typhimurium. We discovered that there was a significantly higher expression of blaTEM, fimA, fimZ, and integrons in the CBD-resistant bacteria, and these were also accompanied by a shift in abundance in cell surface molecules such as lipopolysaccharide (LPS) and sterols.

microbiology↗

bioRxiv2022

CBD resistant Salmonella strains are susceptible to Epsilon 34 phage tailspike protein

The rise of antimicrobial resistance is a global public health crisis that threatens the effective control and prevention of infections. Due to the emergence of pandrug-resistant bacteria, most antibiotics have lost their efficacy. Meanwhile, the development of new antimicrobials has stagnated, which leads to the creation of new and unconventional treatments. Bacteriophages or their components are known to target bacterial cell walls, cell membranes, and lipopolysaccharides (LPS) and hydrolyze them. Bacteriophages being the natural predators of pathogenic bacteria, are inevitably categorized as "human friends", thus fulfilling the adage that "the enemy of my enemy is my friend". Leveraging on their lethal capabilities against pathogenic bacteria, researchers are searching for more ways to overcome the current antibiotic resistance challenge. Bacteriophages are considered to be one of the most effective alternative therapies for multidrug resistant bacteria. In this study, we expressed and purified epsilon 34 phage tailspike protein (E34 TSP) from the E34 TSP gene which was previously cloned into a pET30a-LIC vector, then assessed the ability of this bacteriophage protein in the killing of two CBD-resistant strains of Salmonella spp. We observed that the combined treatment of CBD-resistant strains of Salmonella with CBD and E34 TSP showed poor killing ability whereas the monotreatment with E34 TSP showed considerably higher killing efficiency.

microbiology↗